quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:22:14·717d
INSIDERFiling
American Equity Investment Life Holding Company logo

Boushek Aaron returned 8,611 shares to the company, closing all direct ownership in the company (SEC Form 4)

AEL· American Equity Investment Life Holding Company
Finance
Original source

Companies

  • AEL
    American Equity Investment Life Holding Company
    Finance

Recent analyst ratings

  • Jul 14UpdateTruist$55.00
  • Jun 28UpdateRaymond James-
  • Feb 21UpdatePiper Sandler$48.00
  • Dec 19UpdateRaymond James$48.00
  • Aug 15UpdateEvercore ISI$44.00
  • Jul 22UpdateCredit Suisse$38.00

Related

  • PR324d
    JAB Insurance Names Jin Chang as Partner
  • PR512d
    AM Best Removes From Under Review with Developing Implications and Takes Various Credit Rating Actions on American National Insurance Company and Most of Its Affiliates
  • SEC710d
    SEC Form 15-12G filed by American Equity Investment Life Holding Company
  • SEC713d
    SEC Form 10-Q filed by American Equity Investment Life Holding Company
  • PR714d
    AM Best Places Credit Ratings of North End Re (Cayman) SPC Under Review With Developing Implications
  • SEC715d
    American Equity Investment Life Holding Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
  • 13D/G716d
    SEC Form SC 13G filed by American Equity Investment Life Holding Company
  • INSIDER717d
    Hayes Michael E returned 3,995 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022